-Adrenoceptor Antagonists in the Treatment of Benign Prostatic Hyperplasia

Author： Cooper K.L.   McKiernan J.M.   Kaplan S.A.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.57, Iss.1, 1999-01, pp. : 9-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Subtype selective 1-adrenoceptor antagonists for the treatment of benign prostatic hyperplasia

By Forray C.   Noble S.A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2073-2094

Informa Healthcare

Access to resources Recommend Favorite

α-Adrenoceptor antagonists best choice for initial treatment of lower urinary tract symptoms related to benign prostatic hyperplasia

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 23, Iss. 6, 2007-06 ,pp. : 9-11

Adis International

Access to resources Recommend Favorite

Treatment options for benign prostatic hyperplasia

By Thurlow R.J.  

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 225-246

Informa Healthcare

Access to resources Recommend Favorite

Dutasteride for the treatment of benign prostatic hyperplasia

By Wu Christopher   Kapoor Anil  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 10, 2013-07 ,pp. : 1399-1408

Informa Healthcare

Access to resources Recommend Favorite

Silodosin, a novel selective α1A-adrenoceptor selective antagonist for the treatment of benign prostatic hyperplasia

By Yoshida Masaki   Homma Yukio   Kawabe Kazuki  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 12, 2007-12 ,pp. : 1955-1965

Informa Healthcare

Access to resources Recommend Favorite